About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

TERMINATEDNCT03370861

How Microbes and Metabolism May Predict Skin Cancer Immunotherapy Outcomes

The purpose of this research study is to examine the relationship between the microbiota (microscopic organisms) in the gut and the activity of the immune system during skin cancer immunotherapy.

Lead sponsor: Washington University School of Medicine•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Sponsors

Lead Sponsor

Washington University School of Medicine

Details will be available upon publication.

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•≥18 years of age.
•Diagnosis of skin cancer.
•Planning to initiate or already on ANY type of immunotherapy.
•Able to provide urine and stool specimens.

Exclusion Criteria

•Bowel resection.
•Major GI surgery in the past 5 years other than cholecystectomy and appendectomy.

Related studies

RECRUITINGPhase 2

A Study of Fianlimab, Cemiplimab, and Ipilimumab in People With Melanoma

NCT06594991 · Advanced Melanoma

RECRUITINGPhase 1

A Study of BI 3810944 in Patients With Advanced Cancer

NCT07224425 · Solid Tumours, Melanoma

RECRUITINGPhase 2

A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab

NCT02621021 · Melanoma

Physical Activity Directly Before Immunotherapy (Nivolumab and Ipilimumab) in Melanoma

NCT07564570 · Metastatic Melanoma

RECRUITINGPhase 3

Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain

NCT06500455 · Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: September 5, 2024Terms

Trial snapshot

StatusTERMINATED

Phase—

Enrollment54

Start dateNov 2017

Last updatedSep 5, 2024

Condition

Autoimmunity Melanoma Merkel Cell Carcinoma Squamous Cell Carcinoma of the Skin Basal Cell Carcinoma+1 more

Locations shown

Barnes-Jewish Hosptial

St Louis, Missouri

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 5, 2024Data synced to Clareo: May 16, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions